Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HY
|
Chloe O Rankin |
BUY
Grant, award, or other acquisition
|
Indirect | 733 Added 0.53% |
-
|
Oct 01
2020 |
|
HYLN
|
Thomas J. Healy
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 34,972,856 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Greg Van De Vere
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 22,149 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Howard M Jenkins
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 16,656,790 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Edward E Olkkola
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 166,560 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Edward E Olkkola
Director |
BUY
Grant, award, or other acquisition
|
Direct | 821,610 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Tortoise Ecofin Borrower LLC
> 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct | 894,375 Added 14.36% |
-
|
Oct 01
2020 |
|
HYLN
|
Tortoise Sponsor LLC
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 4,439,605 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Andrew J. Orekar
Director |
BUY
Conversion of derivative security
|
Direct | 40,000 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Frank M Semple
Director |
BUY
Conversion of derivative security
|
Direct | 40,000 Added 50.0% |
-
|
Oct 01
2020 |
|
HYLN
|
Sidney L Tassin
Director |
BUY
Conversion of derivative security
|
Direct | 40,000 Added 50.0% |
-
|
Oct 01
2020 |
|
CSTL
|
Derek J Maetzold
Pres. & Chief Exec. Officer |
SELL
Open market or private sale
|
Direct | 12,640 Reduced 0.88% |
$654,499
$51.78 p/Share
|
Oct 01
2020 |
|
CLW
|
Steve M Bowden
Sr. V.P. |
SELL
Payment of exercise price or tax liability
|
Direct | 184 Reduced 0.47% |
$6,981
$37.94 p/Share
|
Oct 01
2020 |
|
IGMS
|
Michael Stewart Lee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 178 Added 25.0% |
-
|
Oct 01
2020 |
|
IGMS
|
Daniel Shin Yu Chen
Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,020 Reduced 0.85% |
$77,653
$76.13 p/Share
|
Oct 01
2020 |
|
IGMS
|
Daniel Shin Yu Chen
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,850 Added 2.33% |
$3,961
$1.39 p/Share
|
Oct 01
2020 |
|
IGMS
|
Bruce Keyt
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 34.53% |
$73,590
$73.59 p/Share
|
Oct 01
2020 |
|
IGMS
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct | 357 Added 0.38% |
-
|
Oct 01
2020 |
|
IGMS
|
Michael D Loberg
Director |
BUY
Grant, award, or other acquisition
|
Direct | 535 Added 50.0% |
-
|
Oct 01
2020 |
|
IGMS
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct | 357 Added 1.0% |
-
|
Oct 01
2020 |
|
IGMS
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct | 178 Added 0.32% |
-
|
Oct 01
2020 |
|
QTRX
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct | 288 Added 3.19% |
$9,994
$34.7 p/Share
|
Oct 01
2020 |
|
QTRX
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct | 396 Added 3.59% |
$13,741
$34.7 p/Share
|
Oct 01
2020 |
|
QTRX
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct | 520 Added 4.25% |
$18,044
$34.7 p/Share
|
Oct 01
2020 |
|
QTRX
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct | 338 Added 3.25% |
$11,729
$34.7 p/Share
|
Oct 01
2020 |
|
TBI
|
Brannon Lacey
EVP, President - PeopleScout |
BUY
Grant, award, or other acquisition
|
Direct | 28,977 Added 50.0% |
-
|
Oct 01
2020 |
|
ARR
|
John P Hollihan Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,041 Added 2.11% |
-
|
Oct 01
2020 |
|
ARR
|
Carolyn Downey
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,735 Added 4.87% |
-
|
Oct 01
2020 |
|
ARR
|
Stewart J Paperin
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 1,735 Added 3.81% |
-
|
Oct 01
2020 |
|
AVAN-UN
|
Roberto Mignone
Director |
BUY
Open market or private purchase
|
Indirect | 1,000,000 Added 50.0% |
$10,000,000
$10.0 p/Share
|
Oct 01
2020 |
|
CDLX
|
Clifford Sosin
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 40,642 Added 0.91% |
$2,897,775
$71.3 p/Share
|
Oct 01
2020 |
|
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 100.0% |
$6,468,750
$51.75 p/Share
|
Oct 01
2020 |
|
DCPH
|
Michael Douglas Taylor
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 125,000 Added 50.0% |
$236,250
$1.89 p/Share
|
Oct 01
2020 |
|
MORF
|
Robert E Farrell Jr
SVP Finance and CAO |
SELL
Open market or private sale
|
Direct | 3,279 Reduced 4.21% |
$90,533
$27.61 p/Share
|
Oct 01
2020 |
|
MORF
|
Alexey Lugovskoy
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 1,627 Reduced 1.55% |
$44,905
$27.6 p/Share
|
Oct 01
2020 |
|
TWOU
|
John B. Ellis
CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 2,389 Reduced 11.37% |
$83,233
$34.84 p/Share
|
Oct 01
2020 |
|
TWOU
|
John B. Ellis
CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 7,176 Added 25.46% |
-
|
Oct 01
2020 |
|
TWOU
|
James Kenigsberg
Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 15,840 Reduced 10.1% |
$551,866
$34.84 p/Share
|
Oct 01
2020 |
|
TWOU
|
James Kenigsberg
Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct | 35,876 Added 18.62% |
-
|
Oct 01
2020 |
|
TWOU
|
Matthew J. Norden
CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 5,175 Reduced 8.2% |
$180,297
$34.84 p/Share
|
Oct 01
2020 |
|
TWOU
|
Matthew J. Norden
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 15,376 Added 19.59% |
-
|
Oct 01
2020 |
|
TWOU
|
Paul S Lalljie
CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 48,783 Reduced 14.61% |
$1,699,600
$34.84 p/Share
|
Oct 01
2020 |
|
TWOU
|
Paul S Lalljie
CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 39,240 Added 10.51% |
-
|
Oct 01
2020 |
|
TWOU
|
Mark Chernis
CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 25,611 Reduced 11.65% |
$892,287
$34.84 p/Share
|
Oct 01
2020 |
|
TWOU
|
Mark Chernis
CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 59,450 Added 21.29% |
-
|
Oct 01
2020 |
|
DBI
|
Harvey L Sonnenberg
Director |
SELL
Open market or private sale
|
Direct | 23,000 Reduced 89.24% |
$128,800
$5.6 p/Share
|
Oct 01
2020 |
|
MGI
|
Kamila K Chytil
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,419 Reduced 0.54% |
$12,992
$2.94 p/Share
|
Oct 01
2020 |
|
MGI
|
Robert L Villasenor
GC, Corp Sec and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 946 Reduced 0.31% |
$2,781
$2.94 p/Share
|
Oct 01
2020 |
|
MRUS
|
Lex Bakker
SVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 108 Added 2.18% |
-
|
Oct 01
2020 |
|
MRUS
|
Hui Liu
EVP, CBO & Head of Merus US |
BUY
Exercise of conversion of derivative security
|
Direct | 582 Added 1.03% |
-
|
Oct 01
2020 |